REAL-LIFE USE OF BOTULINUM TOXIN TYPE A IN POSTSTROKE SPASTICITY: IS THERE A TIME WINDOW TO START TREATMENT?

被引：0
|
作者：
Freitas, Margarida [1 ]
Rosa, Susana [2 ]
Guimaraes, Bruno [3 ]
Martins, Joana [4 ]
Mesquita, Jose Luis [5 ]
Cardoso, Daniel [6 ]
Jacinto, Jorge [6 ]
机构：
[1] Hosp Garcia de Orta, Dept Phys & Rehabil Med, Almada, Portugal
[2] Ctr Hosp Univ Lisboa Cent CHULC, Dept Phys & Rehabil Med, Lisbon, Portugal
[3] Ctr Hosp Entre Douro & Vouga CHEDV, Dept Phys & Rehabil Med, Santa Maria Feira, Portugal
[4] Ctr Hosp & Univ Coimbra CHUC, Dept Phys & Rehabil Med, Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte CHULN, Dept Phys & Rehabil Med, Lisbon, Portugal
[6] Ctr Med Reabilitacao Alcoitao, Dept Adult Rehabil, Cascais, Portugal
来源：
TOXICON | 2021年 / 190卷
关键词：
AbobotulinumtoxinA; Botulinum toxin; GAS score; IncobotulinumtoxinA; OnabotulinumtoxinA; Poststroke spasticity;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [21] Realworld Botulinum Toxin Type A Treatment Patterns in Patients with Spasticity
    Gratie, Daniel
    Mercer, Daniel W.
    Lee, Jae Hyun
    Gillard, Patrick
    NEUROLOGY, 2022, 98 (18)
  • [22] Management of spasticity with botulinum toxin type A: implementing the treatment algorithm
    O'Brien, C
    EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 : S77 - S81
  • [23] Botulinum toxin type A - Important component in the multimodal treatment of spasticity
    Keppeller, Christina
    NERVENHEILKUNDE, 2006, 25 (11) : 978 - 978
  • [24] Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial
    Wu, Yah-Ting
    Yu, Hui-Kung
    Chen, Li-Ru
    Chang, Chih-Ning
    Chen, Yi-Min
    Hu, Gwo-Chi
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2018, 99 (11): : 2143 - 2150
  • [25] Long-Term Use of Botulinum Toxin: Is Primary Goal Achievement Sustainable for Poststroke Spasticity?
    Ferreira, Eduardo Freitas
    Pinho, Sergio
    Medeiros, Luisa
    Correira, Filipa
    Abreu, Joselda
    Jacinto, Jorge
    TOXICON, 2022, 214 : S19 - S19
  • [26] Inappropriate Conclusions From the Use of Botulinum Toxin for the Treatment of Spasticity
    Zakine, Benjamin
    Maisonobe, Pascal
    Pickett, Andy M.
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 171 - 171
  • [27] Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?
    Hefter, Harald
    Jost, Wolfgang H.
    Reissig, Andrea
    Zakine, Benjamin
    Bakheit, Abdel Magid
    Wissel, Joerg
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2012, 35 (03) : 227 - 233
  • [28] Botulinum Toxin- A Treatment of PostStroke Spasticity Is Associated with Changes in Interhemispheric Parietal Cortex Connectivity
    Hlustik, Petr
    Hok, Pavel
    Veverka, Tomas
    Trneckova, Marketa
    Otruba, Pavel
    Zapletalova, Jana
    Tudos, Zbynek
    Lotze, Martin
    Kanovsky, Petr
    NEUROLOGY, 2023, 100 (17)
  • [29] EUROPEAN CONSENSUS TABLE ON THE USE OF BOTULINUM TOXIN TYPE A IN ADULT SPASTICITY
    Wissel, Joerg
    Ward, Anthony B.
    Erztgaard, Per
    Bensmail, Djamel
    Hecht, Martin J.
    Lejeune, Thierry M.
    Schnider, Peter
    Altavista, Maria C.
    Cavazza, Stefano
    Deltombe, Thierry
    Duarte, Esther
    Geurts, Alexander C. H.
    Gracies, Jean-Michel
    Haboubi, Naseer H. J.
    Juan, Francisco J.
    Kasch, Helge
    Kaetterer, Christian
    Kirazli, Yesim
    Manganotti, Paolo
    Parman, Yesim
    Paternostro-Sluga, Tatjana
    Petropoulou, Konstantina
    Prempeh, Robert
    Rousseaux, Marc
    Slawek, Jaroslaw
    Tieranta, Niko
    JOURNAL OF REHABILITATION MEDICINE, 2009, 41 (01) : 13 - 25
  • [30] Botulinum toxin type-A treatment in spasticity increases the central conduction time to brain stimulation
    Pauri, F
    Boffa, L
    Cassetta, E
    Pasqualetti, P
    Rossini, PM
    TRANSCRANIAL MAGNETIC STIMULATIO N, 1999, (51): : 250 - 259
12345